Cargando…

Income in Multiple Sclerosis Patients with Different Disease Phenotypes

BACKGROUND: Multiple sclerosis (MS) is a disease with profound heterogeneity in clinical course. OBJECTIVE: To analyze sources and levels of income among MS patients in relation to disease phenotype with a special focus on identifying differences/similarities between primary progressive MS (PPMS) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavaliunas, Andrius, Manouchehrinia, Ali, Danylaite Karrenbauer, Virginija, Gyllensten, Hanna, Glaser, Anna, Alexanderson, Kristina, Hillert, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5231357/
https://www.ncbi.nlm.nih.gov/pubmed/28081163
http://dx.doi.org/10.1371/journal.pone.0169460
_version_ 1782494472292007936
author Kavaliunas, Andrius
Manouchehrinia, Ali
Danylaite Karrenbauer, Virginija
Gyllensten, Hanna
Glaser, Anna
Alexanderson, Kristina
Hillert, Jan
author_facet Kavaliunas, Andrius
Manouchehrinia, Ali
Danylaite Karrenbauer, Virginija
Gyllensten, Hanna
Glaser, Anna
Alexanderson, Kristina
Hillert, Jan
author_sort Kavaliunas, Andrius
collection PubMed
description BACKGROUND: Multiple sclerosis (MS) is a disease with profound heterogeneity in clinical course. OBJECTIVE: To analyze sources and levels of income among MS patients in relation to disease phenotype with a special focus on identifying differences/similarities between primary progressive MS (PPMS) and secondary progressive MS (SPMS). METHODS: A total of 6890 MS patients aged 21−64 years and living in Sweden in 2010 were identified for this cross-sectional study. Descriptive statistics, logistic, truncated linear, and zero-inflated negative binomial regression models were used to estimate differences in income between SPMS, PPMS and relapsing-remitting MS (RRMS) patients. RESULTS: RRMS patients earned almost twice as much as PPMS and SPMS patients (on average SEK 204,500, SEK 114,500, and SEK 79,800 in 2010, respectively). The difference in earnings between PPMS and SPMS was not statistically significant when analyzed with multivariable regression. The estimated odds ratio for PPMS patients to have income from earnings was not significantly different from SPMS patients (95% CI 0.98 to 1.59). PPMS and RRMS patients were less likely to receive benefits when compared to SPMS patients (by 6% and 27% lower, respectively). CONCLUSION: Our findings argue for similarities between PPMS and SPMS and highlight the socioeconomic importance of preventing RRMS patients convert to SPMS.
format Online
Article
Text
id pubmed-5231357
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-52313572017-01-31 Income in Multiple Sclerosis Patients with Different Disease Phenotypes Kavaliunas, Andrius Manouchehrinia, Ali Danylaite Karrenbauer, Virginija Gyllensten, Hanna Glaser, Anna Alexanderson, Kristina Hillert, Jan PLoS One Research Article BACKGROUND: Multiple sclerosis (MS) is a disease with profound heterogeneity in clinical course. OBJECTIVE: To analyze sources and levels of income among MS patients in relation to disease phenotype with a special focus on identifying differences/similarities between primary progressive MS (PPMS) and secondary progressive MS (SPMS). METHODS: A total of 6890 MS patients aged 21−64 years and living in Sweden in 2010 were identified for this cross-sectional study. Descriptive statistics, logistic, truncated linear, and zero-inflated negative binomial regression models were used to estimate differences in income between SPMS, PPMS and relapsing-remitting MS (RRMS) patients. RESULTS: RRMS patients earned almost twice as much as PPMS and SPMS patients (on average SEK 204,500, SEK 114,500, and SEK 79,800 in 2010, respectively). The difference in earnings between PPMS and SPMS was not statistically significant when analyzed with multivariable regression. The estimated odds ratio for PPMS patients to have income from earnings was not significantly different from SPMS patients (95% CI 0.98 to 1.59). PPMS and RRMS patients were less likely to receive benefits when compared to SPMS patients (by 6% and 27% lower, respectively). CONCLUSION: Our findings argue for similarities between PPMS and SPMS and highlight the socioeconomic importance of preventing RRMS patients convert to SPMS. Public Library of Science 2017-01-12 /pmc/articles/PMC5231357/ /pubmed/28081163 http://dx.doi.org/10.1371/journal.pone.0169460 Text en © 2017 Kavaliunas et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Kavaliunas, Andrius
Manouchehrinia, Ali
Danylaite Karrenbauer, Virginija
Gyllensten, Hanna
Glaser, Anna
Alexanderson, Kristina
Hillert, Jan
Income in Multiple Sclerosis Patients with Different Disease Phenotypes
title Income in Multiple Sclerosis Patients with Different Disease Phenotypes
title_full Income in Multiple Sclerosis Patients with Different Disease Phenotypes
title_fullStr Income in Multiple Sclerosis Patients with Different Disease Phenotypes
title_full_unstemmed Income in Multiple Sclerosis Patients with Different Disease Phenotypes
title_short Income in Multiple Sclerosis Patients with Different Disease Phenotypes
title_sort income in multiple sclerosis patients with different disease phenotypes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5231357/
https://www.ncbi.nlm.nih.gov/pubmed/28081163
http://dx.doi.org/10.1371/journal.pone.0169460
work_keys_str_mv AT kavaliunasandrius incomeinmultiplesclerosispatientswithdifferentdiseasephenotypes
AT manouchehriniaali incomeinmultiplesclerosispatientswithdifferentdiseasephenotypes
AT danylaitekarrenbauervirginija incomeinmultiplesclerosispatientswithdifferentdiseasephenotypes
AT gyllenstenhanna incomeinmultiplesclerosispatientswithdifferentdiseasephenotypes
AT glaseranna incomeinmultiplesclerosispatientswithdifferentdiseasephenotypes
AT alexandersonkristina incomeinmultiplesclerosispatientswithdifferentdiseasephenotypes
AT hillertjan incomeinmultiplesclerosispatientswithdifferentdiseasephenotypes